Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome

Endocrine

Volumn 41, Issue 3, 2012, Pages 494-500

  Belaya, Zhanna E ^a   Iljin, Alexander V ^a   Melnichenko, Galina A ^a   Rozhinskaya, Liudmila Y ^a   Dragunova, Natalia V ^a   Dzeranova, Larisa K ^a   Butrova, Svetlana A ^a   Troshina, Ekaterina A ^a   Dedov, Ivan I ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Cushing's syndrome; Electrochemiluminescence immunoassay; Enzyme linked immunosorbent assay; Late night salivary cortisol; Obesity

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; CONTROLLED STUDY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LATE NIGHT SALIVARY CORTISOL; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SALIVA ANALYSIS; SALIVA LEVEL; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 84862660854     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9658-3     Document Type: Article

References (36)

1. C. Steffensen, A.M. Bak, K.Z. Rubeck, J.O.L. Jorgensen, Epidemiology of Cushing's syndrome. Neuroendocrinology 92(1), 1-5 (2010)
2. B. Catargi, V. Rigalleau, A. Poussin, N. Ronci-Chaix, V. Bex, V. Vergnot, H. Gin, P. Roger, A. Tabarin, Occult Cushing's syndrome in type-2 diabetes. J. Clin. Endocrinol. Metab. 88, 5808-5813 (2003) (Pubitemid 38033055)
3. G. Leibowitz, A. Tsur, S.D. Chayen, M. Salameh, I. Raz, E. Cerasi, D.J. Gross, Pre-clinical Cushing's syndrome an unexpected frequent cause of poor glycemic control in obese diabetic patients. Clin. Endocrinol. (Oxf). 44, 712-722 (1996)
4. M. Omura, K. Yamaguchi, Y. Kakuta, T. Nishikawa, Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 27, 193-202 (2004) (Pubitemid 38489081)
5. I. Chiodini, M.L. Mascia, S. Muscarella, C. Battista, S. Minisola, M. Arosio, S.A. Santini, G. Guglielmi, V. Garnevale, A. Scillitani, Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann. Intern. Med. 147, 541-548 (2007) (Pubitemid 351664501)
6. I. Chiodini, M. Torlontano, A. Scillitani, M. Arosio, S. Bacci, S. Di Lembo, P. Epaminonda, G. Augello, R. Enrini, B. Ambrosi, G. Adda, V. Trischitta, Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur. J. Endocrinol. 153, 837-844 (2005) (Pubitemid 43020234)
7. C. Davenport, A. Liew, B. Doherty, H.H.N. Win, H. Misran, S. Hanna, D. Kealy, F. Al-Nooh, A. Agha, C.J. Thompson, M. Lee, D. Smith, The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 40, 80-83 (2011)
8. D.A. Vassiliadi, G. Ntali, T. Stratigou, M. Adali, S. Tsagarakis, Abberant cortisol responses to physiological stimuli in patients presenting with bilateral adrenal incidentalomas. Endocrine 40, 437-444 (2011)
9. L.K. Nieman, B.M.K. Biller, J.W. Finding, J. Newell-Price, M.O. Savage, P.M. Stewart, V.M. Montori, The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J. Clin Endocrinol Metab. 93, 1526-1540 (2008) (Pubitemid 351656485)
10. P. Putignano, P. Toja, A. Dubini, P.F. Giraldi, S.M. Corsello, F. Cavaqnini, Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome. J. Clin. Endocrinol Metab 88, 4153-4157 (2003) (Pubitemid 37153715)
11. J.P. Kahn, D.R. Rubinov, C.L. Davis, M. Kling, R.M. Post, Salivary cortisol: a practical method for evaluation of adrenal function. Biol. Psychiatry 23, 335-349 (1988) (Pubitemid 18043536)
12. J. Guechot, J. Fiet, P. Passa, J.M. Villette, B. Gourmel, F. Tabuteau, G. Cathelineau, Dreux C Physiological and pathological variations in saliva cortisol. Horm. Res. 16, 357-364 (1982) (Pubitemid 13250475)
13. P.J. Evans, J.R. Peters, J. Dyas, R.F. Walker, D. Riad-Fahmy, R. Hall, Salivary cortisol levels in true and apparent hypercortisolism. Clin Endocrinol. (Oxf). 20, 709-715 (1984) (Pubitemid 14105344)
14. H. Raff, J.L. Raff, J.W. Finding, Late-night salivary cortisol as a screening test for Cushing's syndrome. J. Clin. Endocrinol. Metab. 83, 2681-2686 (1998) (Pubitemid 28493760)
15. D.A. Papanicolaou, N. Mullen, I. Kyrou, L.K. Nieman, Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J. Clin. Endocrinol. Metab. 87, 4515-4521 (2002) (Pubitemid 35247034)
16. A. Viardot, P. Huber, J.J. Puder, H. Zulewski, U. Keller, B. Muller, Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free and overnight dexamethasone suppression test. J. Clin. Endocrinol. Metab. 90, 5730-5736 (2005) (Pubitemid 41415483)
17. S. Kidambi, H. Raff, J.W. Finding, Limitation of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur. J. Endocrinol. 157, 725-731 (2007)
18. T. Deutschbein, N. Unger, J. Hinrichs, M.K. Walz, K. Mann, S. Petersen, Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenoma. Eur. J. Endocrinol. 161, 747-753 (2009)
19. S. Sakihara, K. Kageyama, Y. Oki, M. Doi, Y. Iwasaki, S. Takayasu, T. Moriyama, K. Terui, T. Nigawara, Y. Hirata, K. Hashimoto, T. Suda, Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome. Endocr. J. 57, 331-337 (2010)
20. H. Raff, S.L. Ettema, D.C. Eastwood, B.T. Woodson, Salivary cortisol in obstructive sleep apnea: the effect of CPAP. Endocrine 40, 137-139 (2011)
21. K.I. Alexandraki, A.B. Grossman, Novel insights in the diagnosis of Cushing's syndrome. Neuroendocrinology 92(1), 35-43 (2010)
22. S.K. Baid, N. Sinaii, M. Wade, D. Rubino, L.K. Nieman, Radioimmunoassay and tandem mass spectrometry measurement of bedtime salivary cortisol levels: a comparison of assays to establish hypercortisolism. J. Clin. Endocrinol. Metab. 92, 3102-3107 (2007) (Pubitemid 47236377)
23. G. Beko, I. Varga, E. Glaz, M. Sereg, K. Feldman, M. Toth, K. Racz, A. Patocs, Cutoff values of midnight salivary cortisol for the diagnosis of overt hypercortisolism are highly influenced by methods. Clin. Chim. Acta 411, 364-367 (2010)
24. S.M. Baid, D. Rubino, N. Sinaii, S. Ramsey, A. Frank, L.K. Nieman, Specificity of screening tests for Cushing's syndrome in an overweight and obese population. J. Clin. Endocrinol. Metab. 94, 3857-3864 (2009)
25. M. Boscaro, G. Arnaldi, Approach to the patient with possible Cushing's syndrome. J. Clin. Endocrinol. Metab. 94, 3121-3131 (2009)
26. M. Nunes, S. Vattaut, J. Corcuff, A. Rault, H. Loiseau, B. Gatta, N. Valli, L. Letenneur, A. Tabarin, Late-night salivary cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456-462 (2009)
27. K.H. Zou, J. O'Maley, L. Mauri, Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 115, 654-657 (2007) (Pubitemid 46226175)
28. O Ajetunmobi, Making sense of critical appraisal (Hodder Arnold part of Hachette, London, 2002). pp. 69-84
29. J.A. Hanley, B.J. McNeil, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36 (1982) (Pubitemid 12142173)
30. J.A. Hanley, B.J. McNeil, A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148, 839-843 (1983) (Pubitemid 13033817)
31. K. Jeyaraman, A.C. Amini, G. Nandita, S.N. Dwivedi, Late-night salivary cortisol in normal subjects and in patients with Cushing's syndrome. Postgrad Med J. 86, 399-404 (2010)
32. C. Carrozza, S.M. Corsello, R.M. Paragliola, F.I.S. Palumbo, P. Locantore, A. Sferrazza, A. Pontecorvi, C. Zuppi, Clinical accuracy of midnight salivary cortisol measured by automated electrochemiluminescence immunoassay method in Cushing's syndrome. Ann. Clin. Biochem. 47, 228-232 (2010)
33. M. Yaneva, G. Kirilov, S. Zacharieva, Midnight salivary cortisol, measured by highly sensitive electrochemiluminescene immunoassay, for the diagnosis of Cushing's syndrome. Cent. Eur. J. Med. 4, 59-64 (2009)
34. M. Sereg, J. Toke, A. Patocs, I. Varga, P. Igaz, N. Szucs, J Horanyi, P. Pusztai, S. Czirjak, E. Glaz, K. Racz, M. Toth, Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids. 76, 38-42 (2011)
35. M. Vogeser, J. Durner, E. Seliger, C. Auernhammer, Measurement of late-night salivary cortisol with an automated immunoassay system. Clin. Chem. Lab. Med. 44, 1441-1445 (2006) (Pubitemid 44967693)
36. CA Carrasco, M Garcia, M Goycoolea, J Cerda, J Berherat, O. Padilla, D. Meza, N. Wohllk, T Quiroga, Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system. Endocrine. (2012). doi:10.1007/s12020-012-9597-z